POTASSIUM CHLORIDE IN LACTATED RINGERS AND DEXTROSE- potassium chloride, sodium chloride, calcium chloride, sodium lactate, and United States - English - NLM (National Library of Medicine)

potassium chloride in lactated ringers and dextrose- potassium chloride, sodium chloride, calcium chloride, sodium lactate, and

hospira, inc. - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid, unspecified form - unii:33x04xa5at), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0 - potassium chloride 1.79 g in 1000 ml - these solutions are indicated in patients requiring parenteral administration of potassium chloride and the replacement of extracellular losses of fluids and electrolytes with minimal carbohydrate calories. solutions containing potassium chloride are contraindicated in diseases where high potassium levels may be encountered. solutions containing lactate are not for use in the treatment of lactic acidosis. to open tear outer wrap at notch and remove solution container. if supplemental medication is desired, follow directions below before preparing for administration. some opacity of the plastic due to moisture absorption during the sterilization process may be observed. this is normal and does not affect the solution quality or safety. the opacity will diminish gradually. to add medication - prepare additive port. prepare additive port. - using aseptic technique and an additive delivery needle of appropriate length, puncture resealable additive port at target area, inner diaphragm and inject. withdraw need

Compound Sodium Lactate Solution for Infusion BP Malta - English - Malta Medicines Authority

compound sodium lactate solution for infusion bp

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - calcium chloride, dihydrate, potassium chloride, sodium chloride, sodium lactate - solution for infusion - calcium chloride dihydrate 0.27 g/l potassium chloride 0.4 g/l sodium chloride 6 g/l sodium lactate 3.2 g/l - blood substitutes and perfusion solutions

B BRAUN COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP 500mL bottle Australia - English - Department of Health (Therapeutic Goods Administration)

b braun compound sodium lactate intravenous infusion bp 500ml bottle

b braun australia pty ltd - sodium chloride, quantity: 6 mg/ml; calcium chloride dihydrate, quantity: 0.27 mg/ml; potassium chloride, quantity: 0.4 mg/ml; sodium lactate, quantity: 3.12 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections - intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. the solution may also be used as a solvent for intravenously administrated drugs where compatibility has been established. compound sodium lactate is particularly suitable for the replacement of extracellular fluid loss when isotonic dehydration is evident and in burn therapy.

Compound Sodium Lactate Intravenous Infusion Malta - English - Malta Medicines Authority

compound sodium lactate intravenous infusion

baxter healthcare limited - calcium chloride, dihydrate, potassium chloride, sodium chloride, sodium lactate - solution for infusion - calcium chloride dihydrate 0.27 gram(s)/litre ; potassium chloride 0.4 gram(s)/litre ; sodium chloride 6 gram(s)/litre ; sodium lactate 3.2 gram(s)/litre - blood substitutes and perfusion solutions

B BRAUN COMPOUND SODIUM LACTATE 1000mL injection Australia - English - Department of Health (Therapeutic Goods Administration)

b braun compound sodium lactate 1000ml injection

b braun australia pty ltd - sodium chloride, quantity: 6 g/l; sodium lactate, quantity: 6.24 g/l; potassium chloride, quantity: 0.4 g/l; calcium chloride dihydrate, quantity: 0.27 g/l - injection, intravenous infusion - excipient ingredients: water for injections - for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. may also be used as a solvent for intravenously administered drugs where compatibility has been established. indications as at 22 august 2005 : compound sodium lactate solution is particularly suitable for replacement of extracellular fluid loss where isotonic dehydration is evident and in burn therapy.

BAXTER Compound Sodium Lactate (Hartmann's Solution) 1000mL injection AHB2324 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter compound sodium lactate (hartmann's solution) 1000ml injection ahb2324

baxter healthcare pty ltd - potassium chloride, quantity: 400 mg/l; sodium lactate, quantity: 3.22 g/l; calcium chloride dihydrate, quantity: 270 mg/l; sodium chloride, quantity: 6 g/l - injection, solution - excipient ingredients: sodium hydroxide; lactic acid; water for injections - is indicated as a source of water and electrolytes. it is also used in patients as a source of bicarbonate in the treatment of mild to moderate metabolic acidosis associated with dehydration or associated with potassium deficiency. these solutions are indicated as methods of intravenous drug delivery, if the drugs are comparable with the solutions. this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

BAXTER Compound Sodium Lactate (Hartmann's Solution) 500mL injection AHB2323 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter compound sodium lactate (hartmann's solution) 500ml injection ahb2323

baxter healthcare pty ltd - calcium chloride dihydrate, quantity: 270 mg/l; sodium lactate, quantity: 3.22 g/l; potassium chloride, quantity: 400 mg/l; sodium chloride, quantity: 6 g/l - injection, solution - excipient ingredients: sodium hydroxide; water for injections - is indicated as a source of water and electrolytes. it is also used in patients as a source of bicarbonate in the treatment of mild to moderate metabolic acidosis associated with dehydration or associated with potassium deficiency. these solutions are indicated as methods of intravenous drug delivery, if the drugs are comparable with the solutions.

Sodium lactate compound infusion 1litre Viaflo bags United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sodium lactate compound infusion 1litre viaflo bags

baxter healthcare ltd - sodium chloride; potassium chloride; calcium chloride; sodium lactate - infusion - 6mg/1ml ; 400microgram/1ml ; 270microgram/1ml ; 3.17mg/1ml

Compound Sodium Lactate Solution for Infusion BP Ireland - English - HPRA (Health Products Regulatory Authority)

compound sodium lactate solution for infusion bp

baxter healthcare limited - sodium chloride; potassium chloride; calcium chloride dihydrate; sodium lactate - solution for infusion - 0 percent volume/volume - solutions affecting the electrolyte balance; electrolytes

BAXTER 0.22% POTASSIUM CHLORIDE and HARTMANN'S SOLUTION injection AHB2954 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 0.22% potassium chloride and hartmann's solution injection ahb2954

baxter healthcare pty ltd - sodium chloride, quantity: 6 g/l; sodium lactate, quantity: 3.22 g/l; potassium chloride, quantity: 2.2 g/l; calcium chloride dihydrate, quantity: 270 mg/l - injection, solution - excipient ingredients: lactic acid; sodium hydroxide; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)